Plausible drug interaction between cyclophosphamide and voriconazole via inhibition of CYP2B6
- 1 August 2021
- journal article
- research article
- Published by Elsevier in Drug Metabolism and Pharmacokinetics
- Vol. 39, 100396
Abstract
No abstract availableKeywords
Funding Information
- Japan Agency for Medical Research and Development (JP20mk0101159)
This publication has 23 references indexed in Scilit:
- A cocktail approach for assessing the in vitro activity of human cytochrome P450s: An overview of current methodologiesJournal of Pharmaceutical and Biomedical Analysis, 2014
- Cyclophosphamide and cancer: golden anniversaryNature Reviews Clinical Oncology, 2009
- Comprehensive In Vitro Analysis of Voriconazole Inhibition of Eight Cytochrome P450 (CYP) Enzymes: Major Effect on CYPs 2B6, 2C9, 2C19, and 3AAntimicrobial Agents and Chemotherapy, 2009
- In vitro metabolism of carbofuran by human, mouse, and rat cytochrome P450 and interactions with chlorpyrifos, testosterone, and estradiolChemico-Biological Interactions, 2004
- ROLE OF ITRACONAZOLE METABOLITES IN CYP3A4 INHIBITIONDrug Metabolism and Disposition, 2004
- In Vivo Pharmacokinetics and Pharmacodynamics of a New Triazole, Voriconazole, in a Murine Candidiasis ModelAntimicrobial Agents and Chemotherapy, 2003
- The Cytochrome P450 2B6 (CYP2B6) Is the Main Catalyst of Efavirenz Primary and Secondary Metabolism: Implication for HIV/AIDS Therapy and Utility of Efavirenz as a Substrate Marker of CYP2B6 Catalytic ActivityThe Journal of Pharmacology and Experimental Therapeutics, 2003
- A comparison of measures of disproportionality for signal detection in spontaneous reporting systems for adverse drug reactionsPharmacoepidemiology and Drug Safety, 2002
- Use of proportional reporting ratios (PRRs) for signal generation from spontaneous adverse drug reaction reportsPharmacoepidemiology and Drug Safety, 2001
- Interaction of Sulfaphenazole Derivatives with Human Liver Cytochromes P450 2C: Molecular Origin of the Specific Inhibitory Effects of Sulfaphenazole on CYP 2C9 and Consequences for the Substrate Binding Site Topology of CYP 2C9Biochemistry, 1996